🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical trial is to compare two treatment regimes, namely...
Status
Recruiting
Location
Tata Memorial Centre
Start Date
2024-03-07
Trial ID
NCT06214572
This is a Phase 3, randomized, double-blind clinical trial aimed at evaluat...
Status
Recruiting
Location
Harbin Medical University Cancer Hospital
Start Date
2025-06-11
Trial ID
NCT06953999
GSK3359609 is an anti-Inducible T cell Co-Stimulator (ICOS) receptor agonis...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-06-23
Trial ID
NCT02723955
The overarching hypothesis of this trial is that the NAPOLI regimen and alt...
Status
Unknown
Location
Klinikum der Universitaet Muenchen - Campus Grosshadern
Start Date
2019-02-15
Trial ID
NCT03487016
Treatments Being Tested
Quisinostat besides its own efficacy, which can potentially lead to better ...
Status
Completed
Location
Russian Oncological Research Center n.a. N. N. Blokhin RAMS
Start Date
2013-08
Trial ID
NCT02728492
Treatments Being Tested
This is a prospective, single-arm trial. The main purpose of the study is t...
Status
Recruiting
Location
Zhejiang Provincial People's Hospital
Start Date
2024-11-15
Trial ID
NCT06722911
Treatments Being Tested
Current studies resulted in a superiority of a combination of nab-paclitaxe...
Status
Completed
Location
Krankenhaus Nordwest gGmbH - Institute of Clinical Cancer Research
Start Date
2014-12
Trial ID
NCT02691052
Treatments Being Tested
This phase II trail will evaluate the efficacy and safety of combining gemc...
Status
Recruiting
Location
Hepatobiliary Surgery Center, Department of General Surgery, Huashan Hospital & Cancer Metastasis Institute, Fudan University
Start Date
2024-10-24
Trial ID
NCT06591650
Treatments Being Tested
This is a single arm, open label Phase II clinical trial to evaluate the ef...
Status
Unknown
Location
Fudan University
Start Date
2021-12-01
Trial ID
NCT05138159
Determine whether viagenpumatucel-L combined with low-dose cyclophosphamide...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2014-07
Trial ID
NCT02117024